SUNPHARMA.NS

Sun Pharmaceutical Industries Limited · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$45.69B

PE Ratio

33.18

EV to Ebitda

—

Earnings Yield

3.00%

Revenue (TTM)

$5.93B

Net Income (TTM)

$1.38B

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

14.00%

Profit Margin

19.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$45.69B

Revenue TTM$5.93B

Shares Outstanding2.40B

Float1019857151

Insider Ownership56.00%

Institutional Ownership29.00%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)14.00%

Rev Growth Est 1Y Forward0.12

EPS Growth (Quarterly YoY)16.00%

EPS Growth Est Quarterly12.73

LT EPS Growth Estimates12.00%

EBITDA Growth (Quarterly YoY)21.00%

Operations19 fields›

Revenue TTM$5.93B

Gross Margin TTM79.00%

Gross Margin (Quarterly)58.00%

Operating Margin TTM26.00%

Operating Margin (Quarterly)26.00%

Operating Expenses TTM$31.6M

Profit Margin TTM19.00%

Profit Margin (Quarterly)22.00%

Net Income TTM$1.38B

EPS TTM45.51

EPS (Quarterly)14.04

EBITDA Margin TTM28.00%

EBITDA Margin (Quarterly)32.00%

EBITDA TTM$1.67B

CFO TTM$594.9M

Capex % of Revenue TTM8.00%

Capital Expenditures$471.9M

FCF % of Revenue (Quarterly)21.00%

FCF TTM$594.9M

Efficiency1 fields›

ROA9.00%

Valuation6 fields›

P/E (TTM)33.18

P/E Forward26.95

PEG1.04

EV/Revenues (TTM)7.42

Earnings Yield3.00%

Payout Ratio41.00%

Liquidity5 fields›

Cash Per Share104.26

Current Ratio2.89

Total Assets$11.48B

Shareholders Equity$8.62B

Interest Expense$31.6M

Yields3 fields›

Payout Ratio41.00%

Earnings Yield3.00%

Buyback Yield0.00%